Involvement of the gut microbiota in cancer cachexia
American Journal of Physiology-Cell Physiology · 01.09.2024 · 327 (3) · C661-C670
DOI: 10.1152/ajpcell.00327.2024 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Physiology-Cell Physiology, erschienen am 01.09.2024. Verfasst von Brandon N VanderVeen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Microbiology and Immunology, School of Medicine Columbia, University of South Carolina, Columbia, South Carolina, United Sta…. Hauptthemen laut MEDLINE: Cachexia, Gastrointestinal Microbiome, Neoplasms, Muscle, Skeletal. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: HHS | NIH | National Cancer Institute (NCI), NCI NIH HHS.
Abstract (Originalsprache)
Cancer cachexia, or the unintentional loss of body weight in patients with cancer, is a multiorgan and multifactorial syndrome with a complex and largely unknown etiology; however, metabolic dysfunction and inflammation remain hallmarks of cancer-associated wasting. Although cachexia manifests with muscle and adipose tissue loss, perturbations to the gastrointestinal tract may serve as the frontline for both impaired nutrient absorption and immune-activating gut dysbiosis. Investigations into the gut microbiota have exploded within the past two decades, demonstrating multiple gut-tissue axes; however, the link between adipose and skeletal muscle wasting and the gut microbiota with cancer is only beginning to be understood. Furthermore, the most used anticancer drugs (e.g. chemotherapy and immune checkpoint inhibitors) negatively impact gut homeostasis, potentially exacerbating wasting and contributing to poor patient outcomes and survival. In this review, we 1) highlight our current understanding of the microbial changes that occur with cachexia, 2) discuss how microbial changes may contribute to adipose and skeletal muscle wasting, and 3) outline study design considerations needed when examining the role of the microbiota in cancer-induced cachexia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Microbiology and Immunology, School of Medicine Columbia, University of South Carolina, Columbia, South Carolina, United States.
- Department of Chemistry and Biochemistry, University of South Carolina, Columbia, South Carolina, United States.
- Department of Cell Biology and Anatomy, University of South Carolina School of Medicine, Columbia, South Carolina, United States.
ORCID-Profile: Brandon N VanderVeen, Thomas D Cardaci, Brooke M Bullard, Kandy T Velazquez, E Angela Murphy
Förderung
- HHS | NIH | National Cancer Institute (NCI)
- NCI NIH HHS
Zitieren
APA
VanderVeen, B. N., Cardaci, T. D., Bullard, B. M., Madden, M., Li, J., Velazquez, K. T., Kubinak, J. L., Fan, D., & Murphy, E. A. (2024). Involvement of the gut microbiota in cancer cachexia. American Journal of Physiology-Cell Physiology, 327(3), C661-C670. https://doi.org/10.1152/ajpcell.00327.2024
Vancouver
VanderVeen BN, Cardaci TD, Bullard BM, Madden M, Li J, Velazquez KT, et al. Involvement of the gut microbiota in cancer cachexia. American Journal of Physiology-Cell Physiology. 2024;327(3):C661-C670. doi:10.1152/ajpcell.00327.2024
BibTeX
@article{VanderVeen2024,
author = {VanderVeen, Brandon N and Cardaci, Thomas D and Bullard, Brooke M and Madden, Michael and Li, Jie and Velazquez, Kandy T and Kubinak, Jason L and Fan, Daping and Murphy, E Angela},
title = {Involvement of the gut microbiota in cancer cachexia},
journal = {American Journal of Physiology-Cell Physiology},
year = {2024},
volume = {327},
number = {3},
pages = {C661--C670},
doi = {10.1152/ajpcell.00327.2024}
}
EUVIMED